Physician

Paul Michael Benson, M.D.

According to 2025 Medicare claims, Paul Benson, M.D. (NPI: 1982607180) practices dermatology in the Johnson City, TN market, with the plurality of this provider's patient population coming from Washington, TN. This provider's primary affiliated billing organization is TRICITIES SKIN AND CANCER (NPI: 1295824415; TIN: 621822644) and primary practice location at 37604-3693.

Benson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,033 traditional Medicare patients, billed 6,562 HCPCS/CPT codes, and received $220,802 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,222 prescription claims across 837 beneficiaries totaling $474,949 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 21 records totaling $471. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,422	7,916	$270,540
2016	1,352	8,264	$286,678
2017	1,409	7,703	$265,728
2018	1,340	7,531	$255,415
2019	1,335	12,138	$271,847
2020	1,168	8,383	$228,696
2021	1,144	11,666	$279,857
2022	1,169	8,997	$243,755
2023	1,172	8,237	$270,144
2024	1,033	6,562	$220,802

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	678	1,673	$222,710
2016	828	1,944	$466,284
2017	881	2,099	$408,071
2018	877	1,995	$508,563
2019	820	1,901	$420,506
2020	665	1,726	$468,154
2021	681	1,615	$452,168
2022	701	1,805	$561,138
2023	770	1,962	$397,458
2024	837	2,222	$474,949

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	476	606	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	899	1,338	$56
11102	Biopsy of related skin growth, first growth	350	420	$53
17000	Destruction of precancer skin growth, 1 growth	534	742	$29
17003	Destruction of precancer skin growth, 2-14 growths	421	2,668	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Taltz Autoinjector	Ixekizumab	14	392	$98,702
Otezla	Apremilast	15	450	$74,236
Dupixent Syringe	Dupilumab	16	448	$58,371
Metronidazole	Metronidazole	114	3,853	$7,741
Ketoconazole	Ketoconazole	273	9,165	$5,126

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$471	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul Michael Benson, M.D.?

Tedicare shows public-source Medicare data for Paul Michael Benson, M.D. (NPI 1982607180), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul Michael Benson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul Michael Benson, M.D.?

Paul Michael Benson, M.D. is linked to TRICITIES SKIN AND CANCER (billing NPI 1295824415) in the available physician profile data.

Does Paul Michael Benson, M.D. have Open Payments data?

Paul Michael Benson, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.